期刊文献+

志贺菌主动外排系统对氟喹诺酮类抗生素耐药性的影响 被引量:1

Effects of the efflux system on resistance to fluoroquinolones of clinical isolates of Shigella
在线阅读 下载PDF
导出
摘要 目的探讨主动外排系统AcrAB—TolC在志贺菌对氟喹诺酮类抗生素耐药性中的作用。方法K.B纸片扩散法及MIC测定2009-2011年天津地区临床分离的144株志贺菌的药敏情况;加入泵抑剂UCCCP(羰基氰氯苯腙)检测耐药菌株对氟喹诺类抗生素敏感性的变化;应用定量PCR研究外排泵基因acrAB-tolC表达以探讨外排泵在菌株对氟喹诺酮耐药中的作用。结果144株志贺菌中,共有5株志贺菌对环丙沙星等氟喹诺酮类抗生素耐药,均为福氏志贺菌。加入泵抑制剂后,5株志贺菌对5种氟喹诺酮类抗生素的MIC下降了4-16倍,而对照菌株对上述药物的MIC没有变化或仅下降至原值的1/2。实时定量PCR结果表明耐药菌株外排泵基因acrA、ac坷和细,c的mRNA水平显著高于敏感野生株(P〈0.05)。结论本地区志贺菌临床株对氟喹诺酮类抗生素环丙沙星及氧氟沙星耐药率最高,为3.47%。AcrAB-TolC外排泵基因的高表达是导致志贺菌对氟喹诺酮类抗生素耐药的主要原因之一。 Objective To investigate the effects of the AcrAB-TolC Pump on the mechanism of fluoroquinolone-resistance of clinical isolates of Shigella. Methods A total of 144 clinical isolates of Shigella identified in Tianjin from 2009 to 2011 were analysed for their antimicrobial susceptibility detected by K-B disk diffusion method and the minimal inhibitory concentratio(MIC). Efflux pump inhibitor CCCP was added to find the change in MICs. Expression levels of acrAB-toIC mRNA were calculated by Real-time PCR to analyse effects of the AcrAB-TolC Pump on resistance to fluoroquinolone of clinical isolates of Shigella. Results Among 144 Shigella strains, 5 isolates of Shigella flexneri are resistant to fluoroquinolon such as ciprofloxacin, all of them are S. flexneri isolates. After the addition of CCCP, MICs of five resistant isolates to five kinds of fluoroquinolone are decreased 4-16 times, however, the MICs of control strains have little change. Results of real-time PCR show the expression level of acrA, acrB and tolC gene in the five resistant strains was significantly higher than that in the susceptible strains(P〈0.05). Conclusion In our area, Shigella clinical isolates have the highest resistant rate of 3.47% to ciprofloxacin and ofloxacin. Overexpression of efflux pump gene is one of the main reasons of fluoroquinolone resistance in Shigella.
出处 《中国抗生素杂志》 CAS CSCD 北大核心 2013年第9期696-699,共4页 Chinese Journal of Antibiotics
基金 天津医科大学校级课题(2010KY47)
关键词 志贺菌 氟喹诺酮 外排泵 Shigella Fluoroquinolone Effiux pump
  • 相关文献

参考文献14

  • 1Zhang W, Luo Y, Li J, et al. Wide dissemination of multidrug-resistant Shigella isolates in China[J]. J Antimicrob Chemother, 2011, 66(11): 2527-35.
  • 2窦红涛,谢秀丽,张小江,徐英春.Mohnarin 2008年度报告:肠杆菌科细菌耐药监测[J].中国抗生素杂志,2010,35(7):556-560. 被引量:41
  • 3梁帆,程玉谦,张娜,王俊,王淑香,郭文学,祁伟.志贺菌临床株耐药性分析及对氟喹诺酮类抗生素耐药机制的研究[J].天津医药,2011,39(11):1009-1012. 被引量:5
  • 4Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing;Twentieth informational supplement. CLSI documents M100-S20[S].Wayne, Pennsylvania, 2010: 1-160.
  • 5Valdezate S, Vindel A, Eclaeita A, et al. Topiosomerase II and IV quinolone resistance-determining regions in Stenotrophomonas maltophilia clinical isolates with different levels of quinolone susceptibility[J]. Antimicrob Agents Chemother, 2002, 46(3): 665-671.
  • 6Khatun F, Faruque A S, Koeck J L, et al. Changing species distribution and antimicrobial susceptibility pattern of Shigella over a 29-year period (1980--2008)[J]. Epidemiol lnfect, 2011, 139(3): 446-452.
  • 7钟豪杰,常昭瑞,张静.中国2007年细菌陛痢疾监测分析[J].中华流行病学杂志,2010,31(3):304-307. 被引量:61
  • 8Gu B, Cao Y, Pan S, et al. Comparison of the prevalence and changing resistance to nalidixic acid and ciprofloxacin of Shigella between Europe-America and Asia-Africa from 1998 to 2009[J]. IntJAntimicrobAgents, 2012, 40(1): 9-17.
  • 9Ghosh A S, Ahamed J, Chauhan K K, et al. Involvement of an effiux system in high-level fluoroquinolone resistance of Shigella dysenteriae[J]. Biochem Biophys Res Commun, 1998, 242(1): 54-56.
  • 10Yang H Y, Duan G C, Zhu J Y, et al. The AcrAB-TolC pump is involved in multidrug resistance in clinical shigella flexneri isolates[J]. Microb Drug Resist, 2008, 14(4): 245-249.

二级参考文献60

  • 1杨海燕,段广才,郗园林.主动外排系统acrAB在志贺菌中分布和表达[J].中国公共卫生,2005,21(6):685-687. 被引量:33
  • 2唐传玲,朱于莉,汪萱怡,赵守军,瞿涤.福氏志贺菌喹诺酮类耐药临床分离株gyrA和parC的基因突变[J].中华传染病杂志,2005,23(3):150-153. 被引量:5
  • 3靳静,桂林艳.小儿细菌感染性腹泻主要菌群变迁分析[J].郑州大学学报(医学版),2006,41(3):590-592. 被引量:6
  • 4戴自英 刘玉昆 等.实用抗菌药物学(第2版)[M].上海:上海科学技术出版社,1999.208-216.
  • 5Jones FT,Chaves SS,Barrett JT,et al.Epidemiology of bacterial enteric infections under active surveillance in Tennessee and Georgia,2000-2002.Tennessee Med,JUL,2004:319-321.
  • 6Gupta A,Polyak SC,Bishop DR,et al.Laboratory-confirmed shigellosis in the United States,1989-2002:epidemiologic trends and patterns.Clin Infect Dis,2004,38:1372-1377.
  • 7Clinical and laboratory Standards Institute.Performance standards for antimicrobial susceptibility testing;Twentieth informational supplement.CLSI documents M100-S20.CLSI,2010.
  • 8Cai J C,Zhou H W,Zhang R,et al.Emergence of Serratia marcescens,Klebsiella pneumoniae,and Escherichia coli isolates possessing the plasmid-mediated carbapenem-hydrolyzing beta-lactamase KPC-2 in intensive care units of a Chinese hospital[J].Antimicrob Agents Chemother,2008,52:2014-2018.
  • 9Brodford P A.Extended-spectrum β-lactamases in the 21 century:characterization,epidemiology and detection of this important resistant threat[J].Clin Microbiol Rev,2001,14:933-951.
  • 10Schw aber M J,Navon-Venezia S,Carmeli Y High level of antimicrobial co-resistance among extended-spectrum β-lactamase-producing Enterobacteriaceae[J].Antimicrob Agents Chem other,2005,49(5):2137-2139.

共引文献135

同被引文献5

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部